November 28, 2015
CHICAGO — The revised guidelines for prostate cancer screening with PSA testing issued by the U.S. Preventive Services Task Force in 2012 reduced the number of screenings among men aged 75 years or older, but not in relation to overall rates.
“With the most recent changes in 2012, the U.S. Preventive Services Task Force (USPSTF) essentially recommended against screening any men for prostate cancer with a digital rectal exam or PSA for men of average risk of getting prostate cancer. They gave it a grade D recommendation,” Simon Kim, MD, MPH, assistant professor of urology and urologic oncology at University Hospital Case Medical Center and Case Western Reserve University School of Medicine in Cleveland, Ohio, and a study investigator, told Healio.com. “[There were] two trials that showed really mixed level evidence [regarding screening]. I think the controversy is because one trial showed no benefit and the other did.”